Annual bulletins on veterinary pharmacovigilance activities (2003-19)

Between 2003 and 2019, the European Medicines Agency (EMA) published annual bulletins to inform veterinarians and the public of the main outcomes of post-marketing surveillance activities for veterinary medicines in a calendar year.

The bulletins summarised recommendations on amending safety warnings and highlights ongoing monitoring activities for centrally authorised products.

The bulletins also included a summary of discussions and agreements at the veterinary Pharmacovigilance Working Party on pharmacovigilance issues with nationally authorised veterinary medicines.

Public bulletin: Veterinary pharmacovigilance 2019

Reference Number: EMA/CVMP/PhVWP/33617/2020

Public bulletin: Veterinary pharmacovigilance 2018

Reference Number: EMA/CVMP/809750/2018

Public bulletin: Veterinary pharmacovigilance 2017

Public bulletin: Veterinary pharmacovigilance 2016

Reference Number: EMA/568976/2016

Public bulletin: Veterinary pharmacovigilance 2015

Reference Number: EMA/CVMP/448211/2015

Public bulletin: Veterinary pharmacovigilance 2014

Reference Number: EMA/CVMP/793263/2014

Public bulletin: Veterinary pharmacovigilance 2013

Reference Number: EMA/CVMP/781698/2013Summary:

This public bulletin is primarily aimed at veterinarians and summarises the main outcome of post-marketing surveillance activities for veterinary medicinal products taken place during 2013 at the level of the European Medicines Agency (EMA), and therefore focuses on centrally authorised products.

Public bulletin: Veterinary pharmacovigilance 2012

Reference Number: EMA/CVMP/PhVWP/717241/2012

Public bulletin: Veterinary pharmacovigilance 2011

Reference Number: EMA/CVMP/PhVWP/987984/2011Summary:

This is the 9th bulletin from the European Medicines Agency on veterinary pharmacovigilance activities, covering the year 2011. The aim of this bulletin is to contribute to the public communication on veterinary medicinal products, particularly on the surveillance of the adverse events and safety issues of veterinary medicines in the European Union (EU). It is addressed to all stakeholders, and particularly to veterinary health professionals.

Public bulletin: Veterinary pharmacovigilance 2010

Reference Number: EMA/CVMP/PhVWP/44873/2011

Committee for medicinal products for veterinary use - EMA public bulletin 2009 on veterinary pharmacovigilance

Reference Number: EMA/CVMP/PhVWP/729768/2009

Committee for medicinal products for veterinary use - EMEA public bulletin 2008 on veterinary pharmacovigilance

Reference Number: EMEA/CVMP/PhVWP/253196/2008

Committee for medicinal products for veterinary use - EMEA public bulletin 2007 on veterinary pharmacovigilance

Reference Number: EMEA/CVMP/PhVWP/72829/2007

Committee for medicinal products for veterinary use - EMEA public bulletin 2006 on veterinary pharmacovigilance

Reference Number: EMEA/CVMP/PhVWP/73213/2006

Committee for medicinal products for veterinary use - EMEA public bulletin 2005 on veterinary pharmacovigilance

Reference Number: EMEA/CVMP/226674/2005

Committee for medicinal products for veterinary use - EMEA public bulletin 2004 on veterinary pharmacovigilance

Reference Number: EMEA/CVMP/066/05-FINAL

Committee for medicinal products for veterinary use - EMEA public bulletin 2003 on veterinary pharmacovigilance

Reference Number: EMEA/CVMP/359/074